Skip to main content

Table 3 Prevalence of pfmdr1 N86Y alleles among the study population

From: Prevalence and factors associated with carriage of Pfmdr1 polymorphisms among pregnant women receiving intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) and artemether-lumefantrine for malaria treatment in Burkina Faso

Codon N86 allele 86Y allele N86 + 86Y alleles Total 86Y allele carriage P*
n % (95%CI) n % (95%CI) n % (95%CI) n % (95%CI)
Total study population
 ANC-1 (N = 151) 131 86.8 (80.3–91.7) 5 3.3 (1.1–7.6) 15 9.9 (5.7–15.9) 20 13.2 (8.3–19.7) 0.77
 Delivery (N = 116) 102 87.9 (80.6–93.2) 2 1.7 (0.2–6.1) 12 10.3 (5.5–17.4) 14 12.1 (6.8–19.4)  
Women infected at ANC-1 and at delivery
 ANC-1 (N = 38) 35 92.1 (78.6–98.3) 1 2.6 (0.1–13.8) 2 5.3 (0.6–17.8) 3 7.9 (1.7–21.4) 0.25
 Delivery (N = 31) 26 83.9 (66.3–94.5) 0 0 5 16.1 (5.4–33.7) 5 16.1 (5.4–33.7)  
Women who received standard IPTp-SP
 ANC-1 (N = 81) 73 90.1 (81.5–95.6) 1 1.2 (0.03–6.7) 7 8.7 (3.6–17.0) 8 9.9 (4.4–18.5) 0.63
 Delivery (N = 56) 49 87.5 (75.9–94.8) 2 3.6 (0.4–12.3) 5 8.9 (3.0–19.6) 7 12.5 (5.2–24.1)  
Women who received CSST/IPTp-SP
 ANC-1 (N = 70) 58 82.9 (72.0–90.8) 4 5.7 (1.6–14.0) 8 11.4 (5.1–21.3) 12 17.1 (9.2–28.0) 0.38
 Delivery (N = 60) 53 88.3 (77.4–95.2) 0 0 7 11.7 (4.8–22.6) 7 11.7 (4.8–22.6)  
  1. *P value for total mutant (86Y) allele carriage versus wild-type (N86) allele carriage